Association of transient dermal mastocytosis and elevated plasma tryptase levels with development of adverse reactions after treatment of onchocerciasis with ivermectin

Journal of Infectious Diseases

Volumn 186, Issue 9, 2002, Pages 1307-1313

  Cooper, Philip J ^a   Schwartz, Lawrence B ^b   Irani, Anne Marie ^b   Awadzi, Kwablah ^c   Guderian, Ronald H ^d   Nutman, Thomas B ^a  

^a NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

^b VIRGINIA COMMONWEALTH UNIVERSITY   (United States)

^c Hohoe Hospital   (Ghana)

^d HOSPITAL VOZANDES   (Ecuador)

Author keywords

[No Author keywords available]

Indexed keywords

EOSINOPHIL PROTEIN X; INTERLEUKIN 5; IVERMECTIN; PLACEBO; TRYPTASE;

ADULT; ARTICLE; CELL COUNT; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEGRANULATION; DISEASE ASSOCIATION; DISEASE SEVERITY; DOUBLE BLIND PROCEDURE; DRUG MEGADOSE; ECUADOR; ENZYME BLOOD LEVEL; EOSINOPHILIA; GHANA; HUMAN; HUMAN CELL; INFLAMMATION; MALE; MAST CELL; MASTOCYTOSIS; ONCHOCERCA VOLVULUS; ONCHOCERCIASIS; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL;

ANIMALS; ANTHELMINTICS; BIOLOGICAL MARKERS; EOSINOPHILIA; HUMANS; INTERLEUKIN-5; IVERMECTIN; LYMPHEDEMA; MAST CELLS; MASTOCYTOSIS, CUTANEOUS; ONCHOCERCA; ONCHOCERCIASIS; SERINE ENDOPEPTIDASES; TRYPTASES;

EID: 0036838276     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/344318     Document Type: Article

References (28)

1. Kephart GM, Gleich GJ, Connor DH, Gibson DW, Ackerman SJ. Deposition of eosinophil granule major basic protein onto microfilariae of Onchocerca volvulus in the skin of patients treated with diethylcarbamazine. Lab Invest 1984;50:51-61.
2. Ackerman SJ, Kephart GM, Francis H, Awadzi K, Gleich GJ, Ottesen EA. Eosinophil degranulation: An immunologic determinant in the pathogenesis of the Mazzotti reaction in human onchocerciasis. J Immunol 1990; 144:3961-9.
3. Wildenburg G, Darge K, Knab J, Tischendorf FW, Bonow I, Buttner DW Lymph nodes of onchocerciasis patients after treatment with ivermectin: Reaction of eosinophil granulocytes and their cationic granule proteins. Trop Med Parasitol 1994;45:87-96.
4. Cooper PJ, Awadzi K, Ottesen EA, Remick D, Nutman TB. Eosinophil sequestration and activation are associated with the onset and severity of systemic adverse reactions following the treatment of onchocerciasis with ivermectin. J Infect Dis 1999;179:738-42.
5. Taylor MJ, Cross HF, Bilo K. Inflammatory responses induced by the filarial nematode Brugia malayi are mediated by lipopolysaccharide-like activity from endosymbiotic Wolbachia bacteria. J Exp Med 2000;191:1429-35.
6. Cross HF, Haarbrink M, Egerton G, Yazdanbakhsh M, Taylor MJ. Severe reactions to filarial chemotherapy and release of Wolbachia endosymbionts into blood. Lancet 2001;358:1873-5.
7. Keiser PB, Reynolds SM, Awadzi K, Ottesen EA, Nutman TB. Bacterial endosymbionts of Onchocerca volvulus in the pathogenesis of posttreatment reactions. J Infect Dis 2002;185:805-11.
8. Schwartz L, Metcalfe DD, Miller JS, Earl H, Sullivan T. Tryptase levels as an indicator of mast-cell activation in systemic anaphylaxis and mastocytosis. N Engl J Med 1987;316:1622-6.
9. Awadzi K, Opoku NO, Addy ET, Quartey BT. The chemotherapy of onchocerciasis. XIX. The clinical and laboratory tolerance of high dose ivermectin. Trop Med Parasitol 1995;46:131-7.
10. Schwartz L, Yunginger JW, Miller J, Bokhari R, Dull D. Time course of appearance and disappearance of human mast cell tryptase in the circulation after anaphylaxis. J Clin Invest 1989;83:1551-5.
11. Steel CS, Lujan-Trangay A, Gonzalez-Peralta C, Zea-Flores G, Nutman TB. Transient changes in cytokine profiles following ivermectin treatment of onchocerciasis. J Infect Dis 1994;170:962-70.
12. Cooper PJ, Guderian RH, Prakash D, et al. RANTES in onchocerciasis: Changes with ivermectin treatment. Clin Exp Immunol 1996;106:462-7.
13. Church MK, Levi-Schaffer F. The human mast cell. J Allergy Clin Immunol 1997;99:155-60.
14. Cooper PJ, Beck L, Espinel I, Paredes W, Guderian RH, Nutman TB. Endothelial expression of RANTES and eotaxin are associated with eosinophil infiltration into the skin after the treatment of onchocerciasis with ivermectin. Clin Immunol 2000;95:51-61.
15. Schwartz LB, Irani AMA. Serum tryptase and the laboratory diagnosis of systemic mastocytosis. Hematol Oncol Clin North Am 2000;14:641-57.
16. Schwartz LB, Sakai K, Bradford TR, et al. The a form of human tryptase is the predominant type present in blood at baseline in normal subjects and is elevated in those with systemic mastocytosis. J Clin Invest 1995; 96:2702-10.
17. Sakai K, Ren S, Schwartz LB. A novel heparin-dependent processing pathway for human tryptase: Autocatalysis followed by activation with dipeptidyl peptidase I. J Clin Invest 1996;97:988-95.
18. Schwartz LB, Bradford TR, Rouse C, et al. Development of a new, more sensitive immunoassay for human tryptase: Use in systemic anaphylaxis. J Clin Immunol 1994;14:190-204.
19. Sperr WR, Jordan JH, Baghestanian M, et al. Expression of mast cell tryptase by myeloblasts in a group of patients with acute myeloid leukemia. Blood 2001;98:2200-9.
20. Wang HW, Tedla N, Lloyd AR, Wakefield D, McNeill HP. Mast cell activation and migration to lymph nodes during induction of an immune response in mice. J Clin Invest 1998;102:1617-26.
21. Irani AM, Huang C, Xia HZ, et al. Immunohistochemical detection of human basophils in late-phase skin reactions. J Allergy Clin Immunol 1998;101: 354-62.
22. Macfarlane AJ, Kon OM, Smith SJ, et al. Basophils, eosinophils, and mast cells in atopic and nonatopic asthma and in late-phase allergic reactions in the lung and skin. J Allergy Clin Immunol 2000;105:99-107.
23. Wildenburg G, Plenge-Bonig A, Renz A, Fischer P, Buttner DW. Distribution of mast cells and their correlation with inflammatory cells around Onchocerca gutturosa, O. tarsicola, O. ochengi, and O. flexuosa. Parasitol Res 1997;83: 109-20.
24. Wildenburg G, Korten S, Buttner DW. Mast cell distribution in nodules of Onchocerca volvulus from untreated patients with generalized onchocerciasis. Parasitology 1998;116:257-68.
25. Korten S, Wildenburg G, Darge K, Buttner DW. Mast cells in onchocercomas from patients with hyperreactive onchocerciasis (sowda). Acta Trop 1998;70: 217-31.
26. Baumann H, Gauldie J. The acute phase response. Immunol Today 1994; 15:74-80.
27. Brattig NW, Buttner DW, Hoerauf A. Neutrophil accumulation around Onchocerca worms and chemotaxis of neutrophils are dependent on Wolbachia endobacteria. Microbes Infect 2001;3:439-46.
28. Turner PF, Rockett FA, Ottesen EA, Francis H, Awadzi K, Clark IA. Interleukin-6 and tumor necrosis factor in the pathogenesis of adverse reactions after treatment of lymphatic filariasis and onchocerciasis. J Infect Dis 1994;169:1071-5.